Glycine From the People's Republic of China: Final Results of Antidumping Duty Administrative Review and Rescission of Administrative Review, in Part; 2015-2016, 47474-47475 [2017-22068]
Download as PDF
47474
Federal Register / Vol. 82, No. 196 / Thursday, October 12, 2017 / Notices
CPEC’s amendment of its Export
Trade Certificate of Review results in the
following membership list:
• Arizona Nut Company, LLC
• ARO Pistachios, Inc.
• Horizon Growers Cooperative, Inc.
• Keenan Farms, Inc.
• Monarch Nut Company
• Nichols Pistachio
• Primex Farms, LLC
• Setton Pistachio of Terra Bella, Inc.
• Zymex Industries, Inc.
No change has been made regarding
the Export Trade, Export Trade
Activities or Methods of Operation
covered by the Certificate.
The amended Certificate of Review is
effective from June 15, 2017, the date on
which the application for an
amendment was deemed submitted.
Dated: October 5, 2017.
Joseph E. Flynn,
Director, Office of Trade and Economic
Analysis, International Trade Administration.
[FR Doc. 2017–21984 Filed 10–11–17; 8:45 am]
DEPARTMENT OF COMMERCE
International Trade Administration
[A–570–836]
Glycine From the People’s Republic of
China: Final Results of Antidumping
Duty Administrative Review and
Rescission of Administrative Review,
in Part; 2015–2016
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: On April 7, 2017, the
Department of Commerce (the
Department) published the preliminary
results of the administrative review of
the antidumping duty order on glycine
from the People’s Republic of China
(PRC), covering the period March 1,
2015, through February 29, 2016. We
invited interested parties to comment on
the preliminary results. We received
comments from a domestic interested
party, GEO Specialty Chemicals, Inc.
(GEO), a respondent, Baoding Mantong
Fine Chemistry Co., Ltd. (Baoding
Mantong) and a U.S. importer, PharmRx Chemical Corporation (Pharm-Rx).
As a result of comments filed by the
parties, we have determined that the
U.S. sale reported by Baoding Mantong
is not a bona fide sale and the review
should be rescinded with respect to this
exporter. The final results remain
unchanged from the preliminary results
of review with respect to the other
respondent, Jizhou City Huayang
Chemical Co., Ltd. (Huayang Chemical).
asabaliauskas on DSKBBXCHB2PROD with NOTICES
AGENCY:
22:35 Oct 11, 2017
Applicable October 12, 2017.
FOR FURTHER INFORMATION CONTACT:
Edythe Artman or Brian Davis, AD/CVD
Operations, Office VI, Enforcement and
Compliance, International Trade
Administration, U.S. Department of
Commerce, 1401 Constitution Avenue
NW., Washington, DC 20230; telephone:
(202) 482–3931 or (202) 482–7924,
respectively.
Background
On April 7, 2017, the Department
published its notice of preliminary
results of review for the administrative
review on glycine from the PRC in the
Federal Register.1 A summary of the
events that occurred since the
Department published these results, as
well as a discussion of the issues raised
by parties for this final determination,
may be found in the Issues and Decision
Memorandum, which is hereby adopted
by this notice.2
Scope of the Order
BILLING CODE 3510–DR–P
VerDate Sep<11>2014
DATES:
Jkt 244001
The product covered by this
antidumping duty order is glycine,
which is a free-flowing crystalline
material, like salt or sugar. Glycine is
produced at varying levels of purity and
is used as a sweetener/taste enhancer, a
buffering agent, reabsorbable amino
acid, chemical intermediate, and a metal
complexing agent. This proceeding
includes glycine of all purity levels.
Glycine is currently classified under
subheading 2922.49.4020 of the
Harmonized Tariff Schedule of the
United States (HTSUS).3 Although the
HTSUS subheading is provided for
convenience and customs purposes, the
written description of the merchandise
under the order is dispositive.
1 See Glycine from the People’s Republic of
China: Preliminary Results of Antidumping Duty
Administrative Review and Rescission of
Antidumping Duty Administrative Review, In Part;
2015–2016, 82 FR 16992 (April 7, 2017)
(Preliminary Results).
2 See Memorandum to Gary Taverman, Deputy
Assistant Secretary for Antidumping and
Countervailing Duty Operations, on the subject of
‘‘Glycine from the People’s Republic of China:
Issues and Decision Memorandum for the Final
Results of Administrative Review and Rescission of
Review, In Part; 2015–2016’’, dated concurrently
with this notice (Issues and Decision
Memorandum).
3 In separate scope rulings, the Department
determined that: (a) D(-) Phenylglycine Ethyl Dane
Salt is outside the scope of the order and (b) PRCglycine exported from India remains the same class
or kind of merchandise as the PRC-origin glycine
imported into India. See Notice of Scope Rulings
and Anticircumvention Inquiries, 62 FR 62288
(November 21, 1997) and Glycine from the People’s
Republic of China: Final Partial Affirmative
Determination of Circumvention of the
Antidumping Duty Order, 77 FR 73426 (December
10, 2012), respectively.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Analysis of Comments Received
All issues raised in the case and
rebuttal briefs by parties to this
administrative review are addressed in
the Issues and Decision Memorandum.
A list of the issues raised by parties is
attached to this notice as Appendix I.
The Issues and Decision Memorandum
is a public document and is on file
electronically via Enforcement and
Compliance’s Antidumping and
Countervailing Duty Centralized
Electronic Service System (ACCESS).
ACCESS is available to registered users
at https://access.trade.gov and it is
available to all parties in the Central
Records Unit, Room B8024 of the main
Department of Commerce building. In
addition, a complete version of the
Issues and Decision Memorandum can
be accessed directly at https://
enforcement.trade.gov/frn/.
The signed and electronic versions of
the Issues and Decision Memorandum
are identical in content.
Changes Since the Preliminary Results
In Comment 1 of the Issues and
Decision Memorandum, the Department
concluded that the sole U.S. sale
reported by Baoding Mantong for the
period of review was not a bona fide
sale. Consequently, we are rescinding
the review with respect to this
company. We made no changes to the
PRC-wide rate assigned to Pharm-Rx’s
Chinese supplier, Huayang Chemical, as
a result of our analysis of the issues.
Final Results of Review
In the Preliminary Results, we
determined that Huayang Chemical
failed to establish its eligibility for a
separate rate and preliminarily
determined to treat the exporter as part
of the PRC-wide entity.4 Because no
party requested a review of the PRCwide entity and the Department no
longer considers the PRC-wide entity as
an exporter conditionally subject to
administrative reviews, we did not
conduct a review of the PRC-wide
entity, and the entity’s rate is not subject
to change in this review.5
Assessment Rates
Pursuant to section 751(a)(2)(C) of the
Tariff Act of 1930, as amended (the Act)
and 19 CFR 351.212(b), the Department
has determined, and CBP shall assess,
antidumping duties on all appropriate
entries of subject merchandise covered
4 See
Preliminary Results at 16992–16993.
Antidumping Proceedings: Announcement
of Change in Department Practice for Respondent
Selection in Antidumping Duty Proceedings and
Conditional Review of the Nonmarket Economy
Entity in NME Antidumping Duty Proceedings, 78
FR 65963 (November 4, 2013).
5 See
E:\FR\FM\12OCN1.SGM
12OCN1
Federal Register / Vol. 82, No. 196 / Thursday, October 12, 2017 / Notices
by this review. The Department intends
to issue assessment instructions to CBP
15 days after the date of publication of
these final results of review.
Accordingly, we will instruct CBP to
liquidate the entries reported by
Baoding Mantong without regard to
antidumping duties. The Department
also intends to instruct CBP to liquidate
entries of subject merchandise from the
exporters identified above as being part
of the PRC-wide entity (including
Huayang Chemical) at the PRC-wide
rate, i.e., 453.79 percent.
Pursuant to a refinement in the
Department’s non-market economy
practice, for entries that were not
reported in the U.S. sales databases
submitted by companies individually
examined during this review, the
Department will instruct CBP to
liquidate such entries at the PRC-wide
rate.6 Additionally, if the Department
determines that an exporter had no
shipments of the subject merchandise,
any suspended entries that entered
under that exporter’s case number (i.e.,
at that exporter’s rate) will be liquidated
at the PRC-wide rate.7
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Cash Deposit Requirements
The following cash deposit
requirements will be effective for all
shipments of subject merchandise
entered, or withdrawn from warehouse,
for consumption on or after the
publication date of the final results of
this administrative review, as provided
by section 751(a)(2)(C) of the Act: (1)
For Baoding Mantong and other
previously investigated or reviewed PRC
and non-PRC exporters which are not
under review in this segment of the
proceeding but received a separate rate
in a previous segment, the cash deposit
rate will continue to be the exporterspecific rate published for the most
recently-completed period; (2) for all
PRC exporters of subject merchandise
which have not been found to be
entitled to a separate rate, the cash
deposit rate will be that for the PRCwide entity (i.e., 453.79 percent); and (3)
for all non-PRC exporters of subject
merchandise which have not received
their own rate, the cash deposit rate will
be the rate applicable to the PRC
exporter(s) that supplied the non-PRC
exporter. These cash deposit
requirements, when imposed, shall
remain in effect until further notice.
6 See Non-Market Economy Antidumping
Proceedings: Assessment of Antidumping Duties, 76
FR 65694 (October 24, 2011).
7 Id.
VerDate Sep<11>2014
22:35 Oct 11, 2017
Jkt 244001
47475
Notification to Importers
DEPARTMENT OF COMMERCE
This notice serves as a final reminder
to importers of their responsibility
under 19 CFR 351.402(f)(2) to file a
certificate regarding the reimbursement
of antidumping duties prior to
liquidation of the relevant entries
during this period of review. Failure to
comply with this requirement could
result in the Department’s presumption
that reimbursement of antidumping
duties occurred and the subsequent
assessment of double antidumping
duties.
International Trade Administration
Notification Regarding Administrative
Protective Order
This notice also serves as a final
reminder to parties subject to
administrative protective order (APO) of
their responsibility concerning the
return or destruction of proprietary
information disclosed under APO in
accordance with 19 CFR 351.305(a)(3),
which continues to govern business
proprietary information in this segment
of the proceeding. Timely written
notification of the return or destruction
of APO materials, or conversion to
judicial protective order, is hereby
requested. Failure to comply with the
regulations and terms of an APO is a
sanctionable violation.
We are issuing and publishing these
results and this notice in accordance
with sections 751(a)(1) and 777(i) of the
Act.
Dated: October 4, 2017.
Gary Taverman,
Deputy Assistant Secretary for Antidumping
and Countervailing Duty Operations
performing the non-exclusive functions and
duties of the Assistant Secretary for
Enforcement and Compliance.
Appendix I
List of Topics Discussed in the Final Issues
and Decision Memorandum
I. Summary
II. List of Issues
III. Background
IV. Scope of the Order
V. Discussion of Interested Party Comments
Comment 1: Bona Fides of Baoding
Mantong’s U.S. Sale
Comment 2: Moot Arguments Concerning
Baoding Mantong’s Margin Calculations
Comment 3: Assignment of the PRC-Wide
Rate to Pharm-Rx Following Judicial
Review of the Rate
VI. Recommendation
[FR Doc. 2017–22068 Filed 10–11–17; 8:45 am]
BILLING CODE 3510–DS–P
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
[A–403–805]
Silicon Metal From Norway:
Preliminary Affirmative Determination
of Sales at Less Than Fair Value,
Preliminary Negative Determination of
Critical Circumstances, Preliminary
Determination of No Shipments,
Postponement of Final Determination,
and Extension of Provisional Measures
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: The Department of Commerce
(the Department) preliminarily
determines that silicon metal from
Norway is being, or is likely to be, sold
in the United States at less than fair
value (LTFV). The period of
investigation (POI) is January 1, 2016,
through December 31, 2016.
DATES: Applicable October 12, 2017.
FOR FURTHER INFORMATION CONTACT:
Brittany Bauer, AD/CVD Operations,
Office II, Enforcement and Compliance,
International Trade Administration,
U.S. Department of Commerce, 1401
Constitution Avenue NW., Washington,
DC 20230; telephone: (202) 482–3860.
SUPPLEMENTARY INFORMATION:
AGENCY:
Background
This preliminary determination is
made in accordance with section 733(b)
of the Tariff Act of 1930, as amended
(the Act). The Department published the
notice of initiation of this investigation
on April 4, 2017.1 On July 26, 2017, the
Department postponed the preliminary
determination of this investigation, and
the revised deadline is now October 4,
2017.2 For a complete description of the
events that followed the initiation of
this investigation, see the Preliminary
Decision Memorandum.3 A list of topics
included in the Preliminary Decision
Memorandum is included as Appendix
II to this notice. The Preliminary
Decision Memorandum is a public
document and is on file electronically
via Enforcement and Compliance’s
Antidumping and Countervailing Duty
1 See Silicon Metal From Australia, Brazil, and
Norway: Initiation of Less-Than-Fair-Value
Investigations, 82 FR 16352 (April 4, 2017)
(Initiation Notice).
2 See Silicon Metal from Australia, Brazil, and
Norway: Postponement of Preliminary
Determinations in the Less-Than-Fair-Value
Investigations, 82 FR 35753 (August 1, 2017).
3 See Memorandum, ‘‘Decision Memorandum for
the Preliminary Determination in the Less-ThanFair-Value Investigation of Silicon Metal from
Norway,’’ dated concurrently with, and hereby
adopted by, this notice (Preliminary Decision
Memorandum).
E:\FR\FM\12OCN1.SGM
12OCN1
Agencies
[Federal Register Volume 82, Number 196 (Thursday, October 12, 2017)]
[Notices]
[Pages 47474-47475]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-22068]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
International Trade Administration
[A-570-836]
Glycine From the People's Republic of China: Final Results of
Antidumping Duty Administrative Review and Rescission of Administrative
Review, in Part; 2015-2016
AGENCY: Enforcement and Compliance, International Trade Administration,
Department of Commerce.
SUMMARY: On April 7, 2017, the Department of Commerce (the Department)
published the preliminary results of the administrative review of the
antidumping duty order on glycine from the People's Republic of China
(PRC), covering the period March 1, 2015, through February 29, 2016. We
invited interested parties to comment on the preliminary results. We
received comments from a domestic interested party, GEO Specialty
Chemicals, Inc. (GEO), a respondent, Baoding Mantong Fine Chemistry
Co., Ltd. (Baoding Mantong) and a U.S. importer, Pharm-Rx Chemical
Corporation (Pharm-Rx). As a result of comments filed by the parties,
we have determined that the U.S. sale reported by Baoding Mantong is
not a bona fide sale and the review should be rescinded with respect to
this exporter. The final results remain unchanged from the preliminary
results of review with respect to the other respondent, Jizhou City
Huayang Chemical Co., Ltd. (Huayang Chemical).
DATES: Applicable October 12, 2017.
FOR FURTHER INFORMATION CONTACT: Edythe Artman or Brian Davis, AD/CVD
Operations, Office VI, Enforcement and Compliance, International Trade
Administration, U.S. Department of Commerce, 1401 Constitution Avenue
NW., Washington, DC 20230; telephone: (202) 482-3931 or (202) 482-7924,
respectively.
Background
On April 7, 2017, the Department published its notice of
preliminary results of review for the administrative review on glycine
from the PRC in the Federal Register.\1\ A summary of the events that
occurred since the Department published these results, as well as a
discussion of the issues raised by parties for this final
determination, may be found in the Issues and Decision Memorandum,
which is hereby adopted by this notice.\2\
---------------------------------------------------------------------------
\1\ See Glycine from the People's Republic of China: Preliminary
Results of Antidumping Duty Administrative Review and Rescission of
Antidumping Duty Administrative Review, In Part; 2015-2016, 82 FR
16992 (April 7, 2017) (Preliminary Results).
\2\ See Memorandum to Gary Taverman, Deputy Assistant Secretary
for Antidumping and Countervailing Duty Operations, on the subject
of ``Glycine from the People's Republic of China: Issues and
Decision Memorandum for the Final Results of Administrative Review
and Rescission of Review, In Part; 2015-2016'', dated concurrently
with this notice (Issues and Decision Memorandum).
---------------------------------------------------------------------------
Scope of the Order
The product covered by this antidumping duty order is glycine,
which is a free-flowing crystalline material, like salt or sugar.
Glycine is produced at varying levels of purity and is used as a
sweetener/taste enhancer, a buffering agent, reabsorbable amino acid,
chemical intermediate, and a metal complexing agent. This proceeding
includes glycine of all purity levels. Glycine is currently classified
under subheading 2922.49.4020 of the Harmonized Tariff Schedule of the
United States (HTSUS).\3\ Although the HTSUS subheading is provided for
convenience and customs purposes, the written description of the
merchandise under the order is dispositive.
---------------------------------------------------------------------------
\3\ In separate scope rulings, the Department determined that:
(a) D(-) Phenylglycine Ethyl Dane Salt is outside the scope of the
order and (b) PRC-glycine exported from India remains the same class
or kind of merchandise as the PRC-origin glycine imported into
India. See Notice of Scope Rulings and Anticircumvention Inquiries,
62 FR 62288 (November 21, 1997) and Glycine from the People's
Republic of China: Final Partial Affirmative Determination of
Circumvention of the Antidumping Duty Order, 77 FR 73426 (December
10, 2012), respectively.
---------------------------------------------------------------------------
Analysis of Comments Received
All issues raised in the case and rebuttal briefs by parties to
this administrative review are addressed in the Issues and Decision
Memorandum. A list of the issues raised by parties is attached to this
notice as Appendix I. The Issues and Decision Memorandum is a public
document and is on file electronically via Enforcement and Compliance's
Antidumping and Countervailing Duty Centralized Electronic Service
System (ACCESS). ACCESS is available to registered users at https://access.trade.gov and it is available to all parties in the Central
Records Unit, Room B8024 of the main Department of Commerce building.
In addition, a complete version of the Issues and Decision Memorandum
can be accessed directly at https://enforcement.trade.gov/frn/. The signed and electronic versions of the Issues and
Decision Memorandum are identical in content.
Changes Since the Preliminary Results
In Comment 1 of the Issues and Decision Memorandum, the Department
concluded that the sole U.S. sale reported by Baoding Mantong for the
period of review was not a bona fide sale. Consequently, we are
rescinding the review with respect to this company. We made no changes
to the PRC-wide rate assigned to Pharm-Rx's Chinese supplier, Huayang
Chemical, as a result of our analysis of the issues.
Final Results of Review
In the Preliminary Results, we determined that Huayang Chemical
failed to establish its eligibility for a separate rate and
preliminarily determined to treat the exporter as part of the
PRC[hyphen]wide entity.\4\ Because no party requested a review of the
PRC-wide entity and the Department no longer considers the PRC-wide
entity as an exporter conditionally subject to administrative reviews,
we did not conduct a review of the PRC-wide entity, and the entity's
rate is not subject to change in this review.\5\
---------------------------------------------------------------------------
\4\ See Preliminary Results at 16992-16993.
\5\ See Antidumping Proceedings: Announcement of Change in
Department Practice for Respondent Selection in Antidumping Duty
Proceedings and Conditional Review of the Nonmarket Economy Entity
in NME Antidumping Duty Proceedings, 78 FR 65963 (November 4, 2013).
---------------------------------------------------------------------------
Assessment Rates
Pursuant to section 751(a)(2)(C) of the Tariff Act of 1930, as
amended (the Act) and 19 CFR 351.212(b), the Department has determined,
and CBP shall assess, antidumping duties on all appropriate entries of
subject merchandise covered
[[Page 47475]]
by this review. The Department intends to issue assessment instructions
to CBP 15 days after the date of publication of these final results of
review. Accordingly, we will instruct CBP to liquidate the entries
reported by Baoding Mantong without regard to antidumping duties. The
Department also intends to instruct CBP to liquidate entries of subject
merchandise from the exporters identified above as being part of the
PRC-wide entity (including Huayang Chemical) at the PRC-wide rate,
i.e., 453.79 percent.
Pursuant to a refinement in the Department's non-market economy
practice, for entries that were not reported in the U.S. sales
databases submitted by companies individually examined during this
review, the Department will instruct CBP to liquidate such entries at
the PRC-wide rate.\6\ Additionally, if the Department determines that
an exporter had no shipments of the subject merchandise, any suspended
entries that entered under that exporter's case number (i.e., at that
exporter's rate) will be liquidated at the PRC-wide rate.\7\
---------------------------------------------------------------------------
\6\ See Non-Market Economy Antidumping Proceedings: Assessment
of Antidumping Duties, 76 FR 65694 (October 24, 2011).
\7\ Id.
---------------------------------------------------------------------------
Cash Deposit Requirements
The following cash deposit requirements will be effective for all
shipments of subject merchandise entered, or withdrawn from warehouse,
for consumption on or after the publication date of the final results
of this administrative review, as provided by section 751(a)(2)(C) of
the Act: (1) For Baoding Mantong and other previously investigated or
reviewed PRC and non-PRC exporters which are not under review in this
segment of the proceeding but received a separate rate in a previous
segment, the cash deposit rate will continue to be the exporter-
specific rate published for the most recently-completed period; (2) for
all PRC exporters of subject merchandise which have not been found to
be entitled to a separate rate, the cash deposit rate will be that for
the PRC-wide entity (i.e., 453.79 percent); and (3) for all non-PRC
exporters of subject merchandise which have not received their own
rate, the cash deposit rate will be the rate applicable to the PRC
exporter(s) that supplied the non-PRC exporter. These cash deposit
requirements, when imposed, shall remain in effect until further
notice.
Notification to Importers
This notice serves as a final reminder to importers of their
responsibility under 19 CFR 351.402(f)(2) to file a certificate
regarding the reimbursement of antidumping duties prior to liquidation
of the relevant entries during this period of review. Failure to comply
with this requirement could result in the Department's presumption that
reimbursement of antidumping duties occurred and the subsequent
assessment of double antidumping duties.
Notification Regarding Administrative Protective Order
This notice also serves as a final reminder to parties subject to
administrative protective order (APO) of their responsibility
concerning the return or destruction of proprietary information
disclosed under APO in accordance with 19 CFR 351.305(a)(3), which
continues to govern business proprietary information in this segment of
the proceeding. Timely written notification of the return or
destruction of APO materials, or conversion to judicial protective
order, is hereby requested. Failure to comply with the regulations and
terms of an APO is a sanctionable violation.
We are issuing and publishing these results and this notice in
accordance with sections 751(a)(1) and 777(i) of the Act.
Dated: October 4, 2017.
Gary Taverman,
Deputy Assistant Secretary for Antidumping and Countervailing Duty
Operations performing the non-exclusive functions and duties of the
Assistant Secretary for Enforcement and Compliance.
Appendix I
List of Topics Discussed in the Final Issues and Decision Memorandum
I. Summary
II. List of Issues
III. Background
IV. Scope of the Order
V. Discussion of Interested Party Comments
Comment 1: Bona Fides of Baoding Mantong's U.S. Sale
Comment 2: Moot Arguments Concerning Baoding Mantong's Margin
Calculations
Comment 3: Assignment of the PRC-Wide Rate to Pharm-Rx Following
Judicial Review of the Rate
VI. Recommendation
[FR Doc. 2017-22068 Filed 10-11-17; 8:45 am]
BILLING CODE 3510-DS-P